Life sciences

#Drug discovery #Events #Genesis 2022 #Healthcare #Life sciences

Comment: Looking ahead to Genesis 2022 

The annual Genesis conference will take place on 7 December 2022 in London, and 5,6 and 8 December online, bringing key opinion leaders, investors and innovators from across the life sciences sector under one roof to exchange insights, debate trends and generate deals. DDW’s Megan Thomas will be in attendance… Read More

#Exclusive Content

Quantum computing
#Collaboration #Life sciences #Quantum computing

Quantum computing collaboration could help slash drug discovery cost 

Algorithmiq, a Helsinki-based quantum computing start-up, has entered into an engagement with IBM to progress in its exploration of quantum algorithms that attempt to solve complex issues in life sciences.   Between IBM’s hardware, software and quantum applications expertise and Algorithmiq’s algorithm developers, the companies hope to explore… Read More

#News

UK on global map
#BioIndustry Association #Biologics / Biotechnology #Equity finance #Finance #Fundraising #Investment #Life sciences #Market reporting #Private investment #Seed funding #UK

UK remains strongest biotech hub in Europe despite general decline

After a disappointing start to the year, the last few months have seen a boost to fundraising for UK biotech companies. DDW’s Diana Spencer unpacks the Q3 figures and annual predictions from the BioIndustry Association1.  While 2021 was the highest year on record for investments into UK biotech and life… Read More

#Business & Investment #Exclusive Content #Market Reports

#Biotechnology #Drug discovery #Life sciences #Pharmacology

What’s interesting about Australian drug discovery? 

Australia’s drug discovery industry shows promise and innovation, as well as business opportunities. DDW’s Megan Thomas takes a look at some of the reasons why we should be keeping an interested eye on the developments coming out of this country.   The Sector Snapshot 2022: Expansion is continuous   The Sector Snapshot… Read More

#Exclusive Content #Market Reports #Trends & Analysis

#AI / data analytics / healthtech / informatics #Life sciences

New appointments strengthen AI drug discovery software operations 

Optibrium, a software and artificial intelligence (AI) solutions developer for drug discovery, has announced three appointments: Michelle Harrison as Head of Strategic Marketing, Chris Khoury as Associate Director of Business Development, and Imran Ghauri as Business Development Manager.   The company says the appointments will bring extensive AI and life science… Read More

#Business & Investment #News

#Acquisition #Clinical trials #Life sciences

Beckley Psytech acquires Eleusis Therapeutics

Clinical stage company Beckley Psytech has entered into an agreement to acquire clinical-stage life science company, Eleusis Therapeutics.   Under the terms of the agreement, which has been approved by shareholders, Beckley Psytech has acquired 100% of Eleusis, receiving full developmental and commercial rights for the company’s assets… Read More

#News

#Biologics #Life sciences #Pharmaceuticals

Podcast: The changing drug discovery landscape

This is the latest episode of the free DDW podcast, “What does the changing drug discovery and development landscape mean for the future?”. It covers three articles written for Volume 22, Issue 4 – Fall 2021 of DDW, narrated by DDW Multimedia Editor Megan Thomas. They are called “The… Read More

#News

Japanese flag
#Biopharmaceutical #Collaboration #Drug discovery #Healthcare #Investment #Life sciences #Market reporting #Start-ups

A review of Japan’s drug discovery landscape  

DDW Multimedia Editor Megan Thomas takes a broad look at the drug discovery and development landscape in Japan and highlights how it is bolstered by government policies, investment, collaboration, start-up ecosystems and academic research.   Japan continues to be one of the largest pharmaceutical markets in the world, despite what the… Read More

#Business & Investment #Editor's Choice #Exclusive Content #Market Reports #Trends & Analysis

Midlothian Science Zone
#Lab space #Laboratory #Life sciences #Midlothian Science Zone #Scotland #Start-ups

New lab space planned for Scotland as sector investment reaches record high

Lab space provider Pioneer Group has begun work on 20,000 square feet of purpose-built lab space at the company’s Edinburgh Technopole campus. Branded Moubray, the new building will cater to all segments of the market – from start-ups to blue-chip companies – and is expected to be finished… Read More

#News

#Automation / robotics #Biotechnology #Drug discovery #Drug screening #ELRIG #Events #Life sciences

Comment: Join the science revolution at Drug Discovery 2022 

ELRIG CEO Sanj Kumar tells readers how they can access the most exciting research and find the latest technologies to propel their projects forward at this year’s Drug Discovery 2022  At ELRIG, our purpose is to support researchers in the life sciences and drug discovery communities to learn, share, innovate,… Read More

#Exclusive Content #Opinion

#Business #Diagnostics #Life sciences

PerkinElmer focuses on life sciences in $2.45bn deal

Life sciences company PerkinElmer will divest its Applied, Food and Enterprise Services to the private equity firm New Mountain Capital in a potential deal worth $2.45 billion. PerkinElmer states that the deal comes at a pivotal moment for the company as it transitions to solely focusing on its Life… Read More

#News

#Investment #Life sciences

New £20m fund launches to support North West life sciences

A new £20 million fund has been launched in the Northwest of England to help support the region’s life sciences sector. The ‘GMC Life Sciences Fund By Praetura’ is a partnership between Greater Manchester Combined Authority (GMCA), Cheshire and Warrington Local Enterprise Partnership (LEP), Bruntwood SciTech and Praetura Ventures. It… Read More

#Business & Investment #News

#Clinical trials #Events #Life sciences #Oncology #Rare disease

BioTrinity 2022: Catalysing growth in the life sciences industry 

BioTrinity 2022 will take place April 26-27, 2022 at 155 Bishopsgate in London, UK.   The BioTrinity conference aims to catalyse growth and supports in-person engagement across the life sciences industry. The event will be attended by early-stage and emerging life sciences R&D companies, investors, large pharma,… Read More

#News

#Analysis #Biotechnology #Health #Life sciences

Listicle: Lithuania’s biotechnology growth strategy

Lithuania is dedicating time and resources establishing itself as a life science and biotechnology hub of excellence. DDW’s Megan Thomas analyses four pillars of Lithuania’s growth strategy, which involves ensuring female scientists take leading roles in industry, focusing on investment, developing a strong talent pool as well establishing itself as a… Read More

#Editor's Choice #Exclusive Content #Listicles #News #Videos

#Healthcare #Life sciences

New role to drive growth of CliniSys products and services globally 

Mark Spencer has joined CliniSys as Senior Vice President of Global Strategy. With 25-years’ experience in the life sciences and healthcare IT industry, Spencer will be charged with driving growth globally.  Moving forward  As the world looks to improve public health now and after the… Read More

#News

#Life sciences #Market reporting #Pharmaceutical research #Public health

How strong is the digital talent in the global pharma sector? 

DDW's Megan Thomas looks at three regions and their approach to digitalisation. 1. United Kingdom  A report published by the Association of the British Pharmaceutical Industry (ABPI) has identified the skills and training conditions needed for the future success of UK life sciences. George Freeman, Minister for Science, Research, and… Read More

#News #Trends & Analysis